However, conflicting data were produced about the relation between peripheral blood-derived activated Th17 cells and CTLA4-Ig induced disease remission in RA patients [26, 27], while peripheral blood-derived activated Treg cells before treatment were found to be significantly higher in RA patients achieving disease remission with CTLA4-Ig [26]. Here, CTLA4 is linked to rheumatoid arthritis.